|Videos|June 15, 2022
Clinical Implications of the TIVO-3 Trial
Author(s)Thomas Hutson, DO, PharmD
Dr Thomas Hutson reviews the TIVO-3 trial, including the most recent data that was presented at ASCO GU.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
Breast Cancer Treatments Awaiting FDA Decisions: 4 to Watch
2
From Precision Medicine to AI: The Future of Cancer Care
3
How Childhood Cancer Care Has Transformed Over the Years
4
FDA Approves Etcamah Plus CDK4/6 Inhibitor for ESR1-Mutated Breast Cancer
5